# The Controversy Behind the World's First Spinal Cord Transplant Medical experts question the validity and safety of a recent experimental spinal procedure. - **Source:** [New Scientist](https://www.newscientist.com/) - **Published:** 2026-10-28 - **Topic:** [Business](https://brifing.si/c/business) - **Original article:** - **On Brifing:** https://brifing.si/s/82cbb1fb-08a0-40e8-8d70-0df7f4bcd5f2 ## Unprecedented Surgical Procedure A medical procedure performed this month in Russia involved the world's first spinal cord transplant. Surgeons reportedly removed a section of a spinal cord from a patient suffering from a complete injury and replaced it with donor tissue. This experimental intervention marks a significant, albeit highly debated, milestone in modern neurosurgical history. ## Absence of Clinical Evidence Despite the magnitude of the surgery, details regarding the methodology and patient outcomes remain remarkably scant. Medical professionals have expressed concern because there is currently little evidence to suggest the procedure will be successful. The lack of transparent data complicates the scientific community's ability to evaluate the safety of this approach. ## Historical Precedents of Failure Medical history serves as a cautionary tale against bypassing established evidence protocols. Previous attempts at synthetic organ transplants, such as replacing tracheas with plastic tubes, resulted in catastrophic complications and patient deaths. Surgeons involved in those cases admitted to skipping large animal testing due to time constraints, leading to tragic, preventable outcomes. ## The Gold Standard Protocol Randomised controlled trials remain the gold standard for validating new medical interventions, despite being costly and time-consuming. These rigorous processes ensure that risks are minimized before human application. While innovation requires courage, the medical field relies on these structured trials to prevent experimental surgeries from causing more harm than the conditions treated. ## Compassionate Use Frameworks For critically ill patients, compassionate-use protocols offer a pathway to access experimental treatments before full clinical validation is complete. This framework is currently being utilized for pig kidney transplant trials. Such protocols provide a regulated environment for innovation, ensuring that high-risk procedures are conducted with oversight rather than through premature, unverified surgical attempts. ## Risk Assessment in Medicine Jonas Salk’s historical polio vaccine development highlights the necessity of calculated risk in medical advancement. Salk tested his vaccine on cells, monkeys, and previously infected children before human trials. Unlike the recent spinal cord transplant, Salk’s approach followed a systematic progression, significantly reducing the probability of failure and ensuring broader safety for patients. ## Scientific Foundation Requirements The ambition to achieve successful spinal cord transplants is a valid medical dream, but it requires a robust scientific foundation. Current surgical techniques must be supported by peer-reviewed data and extensive pre-clinical testing. Without these essential pillars, experimental surgeries risk undermining public trust and potentially harming the very patients they intend to help. ## Prioritizing Evidence Over Ambition While imagination and courage drive medical progress, they cannot replace the necessity of empirical evidence. The recent Russian procedure underscores the tension between pioneering spirit and patient safety. Future advancements in spinal repair must prioritize rigorous scientific validation to ensure that dreams of medical breakthroughs do not result in avoidable human tragedy. ## Sources covering this story - https://www.newscientist.com/article/2595939-why-the-worlds-first-spinal-cord-transplant-is-so-controversial/?utm_campaign=RSS|NSNS&utm_content=home&utm_medium=RSS&utm_source=NSNS — --- _Summary written by Brifing from the original reporting. Copyright in the original article belongs to its publisher; read the full piece at the link above._